Update on Alligator Bioscience's Clinical Trials and Pipeline Progress, Anticipating Positive Outcomes and Partnership Discussions |Søren Bregenholt, CEO, Alligator Bioscience AB. 00:10:00

Share On Facebook Share On Twitter

An interview with Son Regenhold, CEO of a biotech company, discussing updates on their clinical trials, pipeline progress, and anticipated outcomes, alongside upcoming partnership discussions and market expectations.

Recent Videos